Advertisement

Ads Placeholder
Loading...

iMD Companies, Inc.

ICBUPNK
Healthcare
Medical - Diagnostics & Research
$0.001
$0.00(0.00%)
U.S. Market opens in 57h 54m

iMD Companies, Inc. Fundamental Analysis

iMD Companies, Inc. (ICBU) shows moderate financial fundamentals with a PE ratio of -8.48, profit margin of -55.51%, and ROE of 19.60%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.08

Areas of Concern

Operating Margin-1.44%
Cash Position0.33%
Current Ratio0.32
We analyze ICBU's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 10.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
10.3/100

We analyze ICBU's fundamental strength across five key dimensions:

Efficiency Score

Weak

ICBU struggles to generate sufficient returns from assets.

ROA > 10%
-1.11%

Valuation Score

Excellent

ICBU trades at attractive valuation levels.

PE < 25
-8.48
PEG Ratio < 2
0.08

Growth Score

Weak

ICBU faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

ICBU shows balanced financial health with some risks.

Debt/Equity < 1
-0.87
Current Ratio > 1
0.32

Profitability Score

Weak

ICBU struggles to sustain strong margins.

ROE > 15%
19.60%
Net Margin ≥ 15%
-55.51%
Positive Free Cash Flow
No

Key Financial Metrics

Is ICBU Expensive or Cheap?

P/E Ratio

ICBU trades at -8.48 times earnings. This suggests potential undervaluation.

-8.48

PEG Ratio

When adjusting for growth, ICBU's PEG of 0.08 indicates potential undervaluation.

0.08

Price to Book

The market values iMD Companies, Inc. at -1.79 times its book value. This may indicate undervaluation.

-1.79

EV/EBITDA

Enterprise value stands at -5.85 times EBITDA. This is generally considered low.

-5.85

How Well Does ICBU Make Money?

Net Profit Margin

For every $100 in sales, iMD Companies, Inc. keeps $-55.51 as profit after all expenses.

-55.51%

Operating Margin

Core operations generate -1.44 in profit for every $100 in revenue, before interest and taxes.

-1.44%

ROE

Management delivers $19.60 in profit for every $100 of shareholder equity.

19.60%

ROA

iMD Companies, Inc. generates $-1.11 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.11%

Following the Money - Real Cash Generation

Operating Cash Flow

iMD Companies, Inc. generates limited operating cash flow of $-544.73K, signaling weaker underlying cash strength.

$-544.73K

Free Cash Flow

iMD Companies, Inc. generates weak or negative free cash flow of $-640.71K, restricting financial flexibility.

$-640.71K

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

ICBU converts -15.22% of its market value into free cash.

-15.22%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.48

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.08

vs 25 benchmark

P/B Ratio

Price to book value ratio

-1.79

vs 25 benchmark

P/S Ratio

Price to sales ratio

5.13

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.87

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.32

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.20

vs 25 benchmark

ROA

Return on assets percentage

-1.11

vs 25 benchmark

ROCE

Return on capital employed

-6.35

vs 25 benchmark

How ICBU Stacks Against Its Sector Peers

MetricICBU ValueSector AveragePerformance
P/E Ratio-8.4828.45 Better (Cheaper)
ROE19.60%763.00% Weak
Net Margin-55.51%-45265.00% (disorted) Weak
Debt/Equity-0.870.34 Strong (Low Leverage)
Current Ratio0.322795.60 Weak Liquidity
ROA-110.96%-16588.00% (disorted) Weak

ICBU outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews iMD Companies, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ